2,4,6-triamino-5-chloroquinazoline has been researched along with nadp in 1 studies
Studies (2,4,6-triamino-5-chloroquinazoline) | Trials (2,4,6-triamino-5-chloroquinazoline) | Recent Studies (post-2010) (2,4,6-triamino-5-chloroquinazoline) | Studies (nadp) | Trials (nadp) | Recent Studies (post-2010) (nadp) |
---|---|---|---|---|---|
5 | 0 | 0 | 21,608 | 25 | 3,484 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avery, MA; Carvalho, P; Gibellini, F; Hunter, WN; McLuskey, K | 1 |
1 other study(ies) available for 2,4,6-triamino-5-chloroquinazoline and nadp
Article | Year |
---|---|
Inhibition of Leishmania major pteridine reductase by 2,4,6-triaminoquinazoline: structure of the NADPH ternary complex.
Topics: Animals; Binding Sites; Crystallography, X-Ray; Electrons; Enzyme Inhibitors; Hydrogen Bonding; Leishmania major; Methotrexate; Models, Chemical; Models, Molecular; NADP; Oxidoreductases; Protein Conformation; Quinazolines | 2004 |